Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PreserV: A Feasibility Study of Vaginal Dose De-escalation During Brachytherapy in Patients With Cervical Cancer

NCT07855263 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07855263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07855263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PreserV: A Feasibility Study of Vaginal Dose De-escalation During Brachytherapy in Patients With Cervical Cancer
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
February 29, 2032
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer